Business Description
Aspira Pathlab & Diagnostics Ltd
ISIN : INE500C01017
Total Employee Number:
141Compare
Compare
Traded in other countries / regions
540788.India IPO Date
2017-12-05Description
Aspira Pathlab & Diagnostics Ltd is mainly engaged in pathology and related healthcare services. It operates laboratories that conduct a wide range of pathological investigations across branches such as biochemistry, hematology, histopathology, microbiology, immunochemistry, immunology, virology, cytology, and other pathological and radiological tests. The services offered include pathology tests, sonography, X-rays, and radiology. The company also provides various health packages like gynecology profiles, anemia profiles, monsoon profiles, coagulation tests, cancer screening packages, newborn screening and IEM panels, orthopedic profiles, allergy panels, and cardiac profiles. These comprehensive diagnostic services assist in disease diagnosis.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.51 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | 1.72 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 12.11 | |||||
Beneish M-Score | -2.96 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.1 | |||||
3-Year EBITDA Growth Rate | 2.1 | |||||
3-Year Book Growth Rate | 16.1 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 32.27 | |||||
9-Day RSI | 43.98 | |||||
14-Day RSI | 46.6 | |||||
3-1 Month Momentum % | 89.45 | |||||
6-1 Month Momentum % | 74.07 | |||||
12-1 Month Momentum % | 85.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.43 | |||||
Quick Ratio | 1.22 | |||||
Cash Ratio | 0.53 | |||||
Days Inventory | 38.88 | |||||
Days Sales Outstanding | 37.98 | |||||
Days Payable | 60.3 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 76.56 | |||||
Operating Margin % | -0.29 | |||||
Net Margin % | 0.03 | |||||
EBITDA Margin % | 7.74 | |||||
FCF Margin % | 3.02 | |||||
OCF Margin % | 5.82 | |||||
ROE % | 0.05 | |||||
ROA % | 0.04 | |||||
ROIC % | -0.46 | |||||
3-Year ROIIC % | -4.76 | |||||
ROC (Joel Greenblatt) % | 7.2 | |||||
ROCE % | 2.49 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
Price-to-Owner-Earnings | 128.46 | |||||
PS Ratio | 4.5 | |||||
PB Ratio | 9.19 | |||||
Price-to-Tangible-Book | 12.34 | |||||
Price-to-Free-Cash-Flow | 148.25 | |||||
Price-to-Operating-Cash-Flow | 77.01 | |||||
EV-to-EBIT | 281.94 | |||||
EV-to-EBITDA | 57.72 | |||||
EV-to-Revenue | 4.47 | |||||
EV-to-FCF | 148.9 | |||||
Price-to-GF-Value | 1.51 | |||||
Price-to-Projected-FCF | 4.8 | |||||
Earnings Yield (Greenblatt) % | 0.36 | |||||
FCF Yield % | 0.68 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aspira Pathlab & Diagnostics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 249.82 | ||
| EPS (TTM) (₹) | - | ||
| Beta | -0.8231 | ||
| 3-Year Sharpe Ratio | 0.84 | ||
| 3-Year Sortino Ratio | 2.55 | ||
| Volatility % | 109.29 | ||
| 14-Day RSI | 46.6 | ||
| 14-Day ATR (₹) | 3.623206 | ||
| 20-Day SMA (₹) | 103.7 | ||
| 12-1 Month Momentum % | 85.68 | ||
| 52-Week Range (₹) | 49 - 135.88 | ||
| Shares Outstanding (Mil) | 10.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aspira Pathlab & Diagnostics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aspira Pathlab & Diagnostics Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aspira Pathlab & Diagnostics Ltd Frequently Asked Questions
What is Aspira Pathlab & Diagnostics Ltd(BOM:540788)'s stock price today?
The current price of BOM:540788 is ₹106.90. The 52 week high of BOM:540788 is ₹135.88 and 52 week low is ₹49.00.
When is next earnings date of Aspira Pathlab & Diagnostics Ltd(BOM:540788)?
The next earnings date of Aspira Pathlab & Diagnostics Ltd(BOM:540788) is .
Does Aspira Pathlab & Diagnostics Ltd(BOM:540788) pay dividends? If so, how much?
Aspira Pathlab & Diagnostics Ltd(BOM:540788) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Aspira Pathlab & Diagnostics Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers